Estrogen Dominance

Estrogen dominance is a clinical and conceptual term for an excess of estrogen without enough progesterone to balance it. The excess can be absolute, or it can be relative to low progesterone. The term is common in integrative and women's health care. It describes the hormonal setting behind a range of conditions.

Estrogen dominance is not a formal coded diagnosis in standard hormone medicine, and no agreed laboratory cutoffs define it. Restorative medicine looks at how the body works underneath. Estrogen and progesterone balance each other, and the effects of a lost balance can be measured.

Estrogen stimulates tissue growth. Inside cells, estrogen signaling promotes inflammation and cell division.¹ Progesterone has the opposite effect. It blocks signals that cause inflammation. It reduces prostaglandins. It shifts the immune messengers of the body (cytokines) toward types that calm the immune response. It also reduces estrogen receptors directly, which limits the reach of estrogen itself.¹

The two hormones oppose each other, so each one checks the other. When progesterone is absent or too low, the growth signal of estrogen goes unopposed.

The clearest clinical evidence comes from the endometrium, the lining of the uterus. Unopposed estrogen causes the lining to grow. When estrogen acts without progesterone, the lining can overgrow (endometrial hyperplasia). Long-term studies of women with hyperplasia show that the atypical forms turn into cancer at a meaningful rate.²

The mechanism is clear. Estrogen speeds the division of cells in the lining. This constant growth signal, with no progesterone to balance it, is what raises cancer risk.³ The effect reaches a ceiling as the dose rises. The direction, however, is consistent. Unopposed estrogen drives tissue growth, and progesterone protects the tissue.

This imbalance is also implicated in several other conditions. Endometriosis depends on estrogen to grow, and this imbalance is a known contributing factor in the disease. In premenstrual syndrome (PMS), such an imbalance has been proposed as a contributing mechanism.

The imbalance also appears in polyendocrine metabolic ovarian syndrome (PMOS), formerly polycystic ovary syndrome (PCOS). In PMOS, ovulation often does not occur, so progesterone is absent or low for long periods. Estrogen then acts on the lining unopposed.

Each of these conditions has more than one cause. The common thread, however, is clear. The body needs its own progesterone as a counterweight. Without it, tissue growth, inflammation, and disease progression can take hold.

The link to ovulation is where the restorative view draws its sharpest conclusion. Progesterone has a specific source. The corpus luteum forms after ovulation and produces it. A healthy ovulation is required to produce enough progesterone.⁴

From this view, estrogen dominance is at root a low-progesterone problem. A low-progesterone problem is, in turn, at root an ovulation problem. If progesterone is low because ovulation is absent or weak, additional estrogen will not correct the problem.

The solution is to address the ovulatory cycle directly. The restorative approach here follows one rule: support ovulation first. Hormone balance comes from a functioning cycle. It does not come from outside hormones that bypass how the body works.

The luteal phase is when progesterone does most of its work. A short, weak, or absent luteal phase leaves estrogen unchecked for most of the cycle. NaProTechnology protocols assess the entire luteal phase to find where progesterone falls short.

These protocols then support progesterone in a way that works with the cycle and its physiology. See cooperative progesterone replacement for the restorative approach to low levels.

Medical research itself shows a form of estrogen dominance. Studies of women's hormone health studied estrogen too much and prescribed it too often. They treated it as the defining female hormone. Progesterone received far less attention.

Researchers also often confused progesterone with progestins, which are synthetic. Progestins are chemically different drugs with very different effects in the body. Progestins are not progesterone.

This confusion in research has hidden two things. One is the protective role of the body's own progesterone. The other is the distinct risks of the synthetic versions. A correct distinction between the two is the first step to understanding estrogen dominance.